Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-085658

General Counsel sold 1,391 shares at an average $0.74 ($1,035)

From the SEC's structured data for this filing

Trades in this filing

Miller Edward · General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-07-19 Sale : show line 1 in the form −634 $0.75 $476 219,483 D
2024-07-22 Sale : show line 2 in the form −757 $0.74 $560 218,726 D
Open-market sales · 1,391 sh · avg $0.74 · $1,035
Loading xslF345X05/ownership.xml…